Cerebral amyloid angiopathy is linked with worse global cognition, dementia, worse gait and cerebral microbleeds in human studies. A mouse study reports that microglial transplantation protects against angiopathy in Alzheimer's disease mice; another reports that rapamycin reduces it in symptomatic hAPP mice when treatment starts after disease onset.
79 findings in 61 papers from 2002 to 2026, 10 of them since April 2026
“Cerebral amyloid angiopathy exhibited a striking ε4 dose-response (OR = 5.76, 95% CI: 4.20-7.96, p < 0.001; for ε4/ε4 compared to ε3/ε3)”
Antihypertensive agents were not clearly linked with cerebral amyloid angiopathy in humans (autopsy cohort).
“No significant relationship was detected between infarction (presence, type, number and size), lacunes or cerebral amyloid angiopathy and antihypertensive medication use.”
Cerebral amyloid angiopathy increases intracerebral hemorrhage in Cebus (spontaneous aging).
“demonstrated an old hematoma, characterized as low foci in SWI and T2 images with central cavitation, alongside multiple smaller areas of old hemorrhage.”
Cerebral amyloid angiopathy increases Aβ deposition proportion in unit vessel in AD mouse model with increasing age from 8 to 14 months (13.63% to 28.80%).
“the proportion Aβ deposition in the unit vessel can increase from 13.63% to 28.80% upon increasing the age of mice from 8 months old to 14 months old”
Animalsin AD mouse model with increasing age from 8 to 14 monthscerebral blood vessels
Cerebral amyloid angiopathy is linked with worse gait in humans (compared to normal controls).
“CAA and Alzheimer disease had similarly impaired Rhythm, Pace, and Variability, and higher dual task cost than normal controls or mild cognitive impairment.”
WSB.APP/PS1 mice increases cerebral amyloid angiopathy in mice (age-dependent; mild at 8 months, robust at 14 months) (mild at 8 months, robust at 14 months).
“We show that WSB.APP/PS1 mice show mild CAA at 8M, with robust CAA being apparent at 14M.”
Animalsage-dependent; mild at 8 months, robust at 14 months
APOE is linked with a higher risk of cerebral amyloid angiopathy in amyloid-positive AD dementia, ε4/ε4 compared to ε3/ε3 (OR = 5.76, 95% CI: 4.20-7.96).
“Cerebral amyloid angiopathy exhibited a striking ε4 dose-response (OR = 5.76, 95% CI: 4.20-7.96, p < 0.001; for ε4/ε4 compared to ε3/ε3)”
Humansin amyloid-positive AD dementia, ε4/ε4 compared to ε3/ε3brain
APOE is linked with a higher risk of cerebral amyloid angiopathy in humans (longitudinally compared to reference group).
“higher CAA risk was observed among males, older individuals, smokers, people with diabetes/heart conditions/lower MMSE scores, and APOE-ε4 carriers compared to their reference groups.”
Alzheimer's & dementia : the journal of the Alzheimer's Association·
APOE is linked with a higher risk of cerebral amyloid angiopathy in participants with type 2 diabetes and APOE epsilon4 allele (RR 6.6, 95% CI 1.5-29.6).
“they had a higher risk of cerebral amyloid angiopathy (RR 6.6, 1.5-29.6)”
Humansin participants with type 2 diabetes and APOE epsilon4 allelebrainmalesn = 216
Cerebral amyloid angiopathy is associated with brain iron in humans (adjusted for demographics, intermediate/high ADNC, and other pathologies) (Est = 0.033, SE = 0.011, p = 0.002).
“the presence and severity of CAA were associated with elevated cortical brain iron (Est = 0.033, SE = 0.011, p = 0.002; Est = 0.017, SE = 0.004, p < 0.001, respectively).”
Humansadjusted for demographics, intermediate/high ADNC, and other pathologiesinferior temporal cortexn = 626
Cerebral amyloid angiopathy is associated with cognitive function in humans (p <0.024).
“both CAA and elevated iron level were independently associated with faster decline in global cognition and three cognitive domains (episodic, semantic, and perceptual speed) (all p <0.024).”
Cerebral amyloid angiopathy is associated with blood pressure variability in humans (pre-morbid 10 years before first-ever ICH) (14 vs. 17 mmHg, P = 0.033).
“patients with moderate-severe CAA had similar mean SBP (143 vs. 145 mmHg, P = 0.588) but lower SBP variability (SBP standard deviation [SD] 14 vs. 17 mmHg, P = 0.033)”
Humanspre-morbid 10 years before first-ever ICH56% femalesn = 72
The changes were linked to a 4.06-point higher dementia rating score, compared with 3.78 points for moderate or severe Alzheimer’s-related changes.The changes were linked to a 4.06-point higher dementia rating score, compared with 3.78 points for moderate or severe Alzheimer’s-related changes.
Alzheimer’s changes statistically accounted for 13–29% of small-artery thickening’s links to poorer thinking, versus 64–91% for amyloid protein buildup in brain vessels.Alzheimer’s changes statistically accounted for 13–29% of small-artery thickening’s links to poorer thinking, versus 64–91% for amyloid protein buildup in brain vessels.
Who was studied1,269 deceased adults with brain autopsies
What changedAlzheimer’s changes statistically accounted for approximately 13-29% of small-artery thickening’s links to poorer thinking and 64-91% for brain-vessel amyloid buildup
The catchAlzheimer’s changes could precede vascular damage, reversing the assumed mediation pathway
An observational study followed 2,033 older adults for 9.1 years on average, linking falling blood pressure more strongly to small-artery disease in women.An observational study followed 2,033 older adults for 9.1 years on average, linking falling blood pressure more strongly to small-artery disease in women.
An animal experiment compared scans with brain tissue in young and older squirrel monkeys, linking an imaging measure to amyloid vessel disease and tissue injury.An animal experiment compared scans with brain tissue in young and older squirrel monkeys, linking an imaging measure to amyloid vessel disease and tissue injury.
In an observational study of 735 people, other brain vessel injuries strengthened links between shorter sleep and brain lesions in some diagnostic groups.In an observational study of 735 people, other brain vessel injuries strengthened links between shorter sleep and brain lesions in some diagnostic groups.
Over a median 5.1 years, bleeding-related lesions appeared in 33.7% of participants with severe enlargement versus 13.6% without severe enlargement.Over a median 5.1 years, bleeding-related lesions appeared in 33.7% of participants with severe enlargement versus 13.6% without severe enlargement.